• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17233

【品名】1-phenyl-3-hexanone

【CA登记号】

【 分 子 式 】C12H16O

【 分 子 量 】176.25844

【元素组成】C 81.77% H 9.15% O 9.08%

与该中间体有关的原料药合成路线共 5 条

合成路线1

该中间体在本合成路线中的序号:(IX)

The condensation of 4(R)-phenyloxazolidin-2-one (I) with 2(E)-pentenoyl chloride (II) by means of BuLi in THF gives 3-[2(E)-pentenoyl]-3(R)-phenyloxazolidin-2-one (III), which is treated with 3-[bis(trimethylsilyl)amino]phenylmagnesium bromide (IV) and CuBr in DMSO/THF regioselectively yielding the addition product (V). Elimination of the silyl groups of (VII) in mild acidic conditions and treatment of the resulting amine with benzyl bromide affords the dibenzylated amine derivative (VI), which is regioselectively acylated with 2-methoxy-2-methyl-1,3-dioxolane (V) and TiCl4 in dichloromethane under basic conditions giving the dione (VIII). The condensation of (VIII) with 1-phenyl-3-hexanone (IX) by means of Ti(OBu)Cl3 in dichloromethane as before yields the hydroxy-dione (X), which is cyclized by means of potassium tert-butoxide in THF to afford the dihydropyrone (XI). The debenzylation of (XI) by hydrogenation with H2 over Pd/C in methanol/ethyl acetate gives the free amine (XII), which is finally sulfonated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride (XIII) in pyridine/dichloromethane

1 Graul, J.; Wroblewski, T.; Castañer, J.; PNU-140690. Drugs Fut 1998, 23, 2, 146.
2 Romines, K.R.; Bundy, G.L.; Schwartz, T.M.; Tommasi, R.A.; Strohbach, J.W.; Turner, S.R.; Thaisrivongs, S.; Aristoff, P.A.; Johnson, P.D.; Skulnick, H.I.; Skaletzki, L.L.; Anderson, D.J.; Morris, J.; Gammill, R.B.; Luke, G.P. (Pharmacia Corp.); Pyranone cpds. useful to treat retroviral infections. EP 0758327; JP 1997512821; US 5852195; WO 9530670 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12173 (4S)-4-Phenyl-1,3-oxazolan-2-one; (4S)-4-Phenyl-2-oxazolidinone; (S)-(+)-4-Phenyl-2-oxazolidinone 99395-88-7 C9H9NO2 详情 详情
(II) 17226 (E)-2-pentenoyl chloride C5H7ClO 详情 详情
(III) 17227 (4R)-3-[(E)-2-pentenoyl]-4-phenyl-1,3-oxazolan-2-one C14H15NO3 详情 详情
(IV) 17228 N-(3-methylphenyl)-N,N-bis(trimethylsilyl)amine; trimethyl-N-(3-methylphenyl)-N-(trimethylsilyl)silanamine C13H25NSi2 详情 详情
(V) 17229 (4R)-3-((3S)-3-[3-[bis(trimethylsilyl)amino]phenyl]pentanoyl)-4-phenyl-1,3-oxazolan-2-one C26H38N2O3Si2 详情 详情
(VI) 17230 (4R)-3-[(3S)-3-[3-(dibenzylamino)phenyl]pentanoyl]-4-phenyl-1,3-oxazolidin-2-one C34H34N2O3 详情 详情
(VII) 17231 2-methoxy-2-methyl-1,3-dioxolane; methyl 2-methyl-1,3-dioxolan-2-yl ether C5H10O3 详情 详情
(VIII) 17232 (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione C36H36N2O4 详情 详情
(IX) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(X) 17234 (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-1,3-octanedione C48H52N2O5 详情 详情
(XI) 17235 (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C39H43NO3 详情 详情
(XII) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(XIII) 17237 5-(trifluoromethyl)-2-pyridinesulfonyl chloride C6H3ClF3NO2S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

1) The condensation of 1-phenylhexan-3-one (I) with ethyl acetate by means of butyllithium and diisopropylamine in THF gives racemic 3-hydroxy-3-(2-phenylethyl)hexanoic acid ethyl ester (II), which is hydrolyzed with NaOH in methanol to the corresponding free acid (III). The optical resolution of (III) with (1R,2S)-(-)-norephedrine (IV) followed by treatment with aqueous HCl yields the chiral (R)-acid (V), which is treated with 4-biphenylyloxymethyl chloride (VI) and diisopropylethylamine in toluene affording the protected ester (VII). The reduction of the ester group of (VII) with diisobutylaluminum hydride (DIBAL) in toluene gives the monoprotected diol (VIII), which is oxidized at the primary hydroxy group with 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy radical (TEMPO) and NaOCl yielding the corresponding aldehyde (IX). The condensation of (IX) with (R)-3-(3-nitrophenyl)pentanoic acid methyl ester (X) by means of sodium hexamethyldisilazide (NaHMDS) in THF gives the hydroxyester (XI) as a mixture of four diastereomers. This mixture is oxidized with pyridinium chlorochromate (PCC) in dichloromethane to afford the ketoester (XII) also as a mixture of two diastereomers. Elimination of the biphenylyloxymethyl protecting group with H2SO4 in methanol yields the hydroxy ketoester (XIII).

1 Fors, K.S.; et al.; A convergent, scalable synthesis of HIV protease inhibitor PNU-140690. J Org Chem 1998, 63, 21, 7348.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
17491 ethyl acetate 141-78-6 C4H8O2 详情 详情
(I) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(II) 21156 ethyl 3-hydroxy-3-phenethylhexanoate C16H24O3 详情 详情
(III) 21157 3-hydroxy-3-phenethylhexanoic acid C14H20O3 详情 详情
(IV) 13355 2-Amino-1-phenyl-1-propanol; (1S,2R)-(+)-Norephedrine 37577-28-9 C9H13NO 详情 详情
(IV) 21158 (1R,2S)-2-amino-1-phenyl-1-propanol C9H13NO 详情 详情
(V) 21159 (3R)-3-hydroxy-3-phenethylhexanoic acid C14H20O3 详情 详情
(VI) 21160 [1,1'-biphenyl]-4-yl chloromethyl ether; 4-(chloromethoxy)-1,1'-biphenyl C13H11ClO 详情 详情
(VII) 21161 ([1,1'-biphenyl]-4-yloxy)methyl (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethylhexanoate C40H40O5 详情 详情
(VIII) 21162 (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethyl-1-hexanol C27H32O3 详情 详情
(IX) 21163 (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethylhexanal C27H30O3 详情 详情
(X) 21164 methyl (3S)-3-(3-nitrophenyl)pentanoate C12H15NO4 详情 详情
(XI) 21165 methyl (5R)-5-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-5-phenethyloctanoate C39H45NO7 详情 详情
(XII) 21166 methyl (5R)-5-[([1,1'-biphenyl]-4-yloxy)methoxy]-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate C39H43NO7 详情 详情
(XIII) 21167 methyl (5R)-5-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate C26H33NO6 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

A new synthesis of PNU-140690 has been developed: The condensation of 1-phenyl-3-hexanone (I) with methyl acetoacetate (II) by means of NaH in THF, followed by cyclization gives the hydroxypyrone (III), which by condensation with 3-nitrobenzaldehyde (IV) by means of AlCl3 in THF yields the benzylidene-pyrone (V). The alkylation of (V) with Et3Al, CuBr-Me2S in THF affords intermediate (VI), which is reduced at the nitro group with H2 over Pd/C in methanol giving the racemic amine (VII). The optical resolution of the N-benzyloxycarbonyl derivative of (VII) with chiral HPLC yielded the desired (R,R)-enantiomer (VIII), which was finally sulfonated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride (IX) in pyridine/dichloromethane.

1 Turner, S.R.; Strohbach, J.W.; Tommasi, R.A.; Aristoff, P.A.; Johnson, P.D.; Skulnick, H.I.; Dolak, L.A.; Seest, E.P.; Tomich, P.K.; Bohanon, M.J.; Horng, M.M.; Lynn, J.C.; Chong, K.T.; Hinshaw, R.R.; Watenpaugh, K.D.; Janakiraman, M.N.; Thaisrivongs, S.; Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem 1998, 41, 18, 3467.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(II) 11791 methyl 3-oxobutanoate; Methyl acetoacetate 105-45-3 C5H8O3 详情 详情
(III) 32879 4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C16H20O3 详情 详情
(IV) 12646 3-Nitrobenzaldehyde 99-61-6 C7H5NO3 详情 详情
(V) 32880 3-[(Z)-(3-nitrophenyl)methylidene]-6-phenethyl-6-propyldihydro-2H-pyran-2,4-dione C23H23NO5 详情 详情
(VI) 32881 4-hydroxy-3-[1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H29NO5 详情 详情
(VII) 32882 3-[1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(VIII) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(IX) 17237 5-(trifluoromethyl)-2-pyridinesulfonyl chloride C6H3ClF3NO2S 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

 

1 Wilken J. Nerenz F, Kanschik-Conndsen A. 2004. A process for the synthesis of 3-hydroxy3-(2-phenylethyl) hexanoic acid,useful as an intermediate for antiviral. US 2004110957(本专利属于Honey-well International, Inc.,USA)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 21159 (3R)-3-hydroxy-3-phenethylhexanoic acid C14H20O3 详情 详情
(VII) 66860 (S)-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one   C16H20O3 详情 详情
(I) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(II) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(III) 21156 ethyl 3-hydroxy-3-phenethylhexanoate C16H24O3 详情 详情
(IV) 13355 2-Amino-1-phenyl-1-propanol; (1S,2R)-(+)-Norephedrine 37577-28-9 C9H13NO 详情 详情
(VI) 66856 (S)-ethyl 5-hydroxy-3-oxo-5-phenethyloctanoate   C18H26O4 详情 详情
(IX) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VIII)

 

1 Judge TM, Phillips G, Moms JK, et aL. 1997. A symmetric syntheses and absolute stereochemistry of 5,6-dihydro-α-pyrones, a new class of potent HIV proteese inhibitors. J Am Chem Soc, 119 (15): 3627~3628
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12173 (4S)-4-Phenyl-1,3-oxazolan-2-one; (4S)-4-Phenyl-2-oxazolidinone; (S)-(+)-4-Phenyl-2-oxazolidinone 99395-88-7 C9H9NO2 详情 详情
(II) 17227 (4R)-3-[(E)-2-pentenoyl]-4-phenyl-1,3-oxazolan-2-one C14H15NO3 详情 详情
(III) 17228 N-(3-methylphenyl)-N,N-bis(trimethylsilyl)amine; trimethyl-N-(3-methylphenyl)-N-(trimethylsilyl)silanamine C13H25NSi2 详情 详情
(V) 17231 2-methoxy-2-methyl-1,3-dioxolane; methyl 2-methyl-1,3-dioxolan-2-yl ether C5H10O3 详情 详情
(VI) 17232 (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione C36H36N2O4 详情 详情
(XI) 66877 2-(1-(3-(dibenzylamino)phenyl)propyl)-5-hydroxy-1-(2-oxo-4-phenyloxazolidin-3-yl)-5-phenethyloctane-1,3-dione   C48H52N2O5 详情 详情
(IV) 17229 (4R)-3-((3S)-3-[3-[bis(trimethylsilyl)amino]phenyl]pentanoyl)-4-phenyl-1,3-oxazolan-2-one C26H38N2O3Si2 详情 详情
(VII) 10385 4-Heptanone; Dipropyl ketone 123-19-3 C7H14O 详情 详情
(VIII) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(IX) 66878 2-(1-(3-(dibenzylamino)phenyl)propyl)-5-hydroxy-1-(2-oxo-4-phenyloxazolidin-3-yl)-5-propyloctane-1,3-dione   C43H50N2O5 详情 详情
(X) 17234 (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-1,3-octanedione C48H52N2O5 详情 详情
(XII) 66875 3-(1-(3-(dibenzylamino)phenyl)propyl)-4-hydroxy-6,6-dipropyl-5,6-dihydro-2H-pyran-2-one   C34H41NO3 详情 详情
(XIII) 17235 (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C39H43NO3 详情 详情
(XIV) 66876 N-(3-(1-(4-hydroxy-2-oxo-6,6-dipropyl-5,6-dihydro-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide   C26H31F3N2O5S 详情 详情
(XVI) 17238 1-phenyl-4-hexyn-3-one C12H12O 详情 详情
(XVII) 17239 (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-6-octyne-1,3-dione C48H48N2O5 详情 详情
(XVIII) 17240 (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-(1-propynyl)-5,6-dihydro-2H-pyran-2-one C39H39NO3 详情 详情
(XIX) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
Extended Information